New pacemaker system aims to improve heart rhythm therapy

NCT ID NCT06620237

Ongoing Disease control Sponsor: Biotronik SE & Co. KG Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests the safety and performance of a new pacemaker system (Amvia pacemaker and Solia CSP S lead) for people who need help with their heart's electrical system. The device is designed to pace a specific part of the heart's natural wiring to improve efficiency. 152 participants will be followed for at least a year to monitor for any serious side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRADYCARDIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac Bradycardia cardiac conduction defect Cardiac Conduction System Disease heart conduction disease heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRADYCARDIA CARDIAC PACEMAKER, ARTIFICIAL CARDIAC PACING, ARTIFICIAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES CONDUCTION DEFECT, CARDIAC CONDUCTION DISORDER HEART FAILURE

Contacts and locations

Locations

AZ Sint-Jan

Bruges, 8000, Belgium
Auckland City Hospital

Grafton, 1023, New Zealand
Catharina Ziekenhuis

Eindhoven, 5623 EJ, Netherlands
Centre Hospitalier Metz-Thionville

Metz, 57038, France
Clinique Saint-Pierre Ottignies

Ottignies, 1340, Belgium
Grand Hôpital de Charleroi

Charleroi, 6060, Belgium
Hopital de la Timone (CHU La Timone)

Marseille, 13005, France
Hôpital Haut Lévêque (CHU)

Pessac, 33600, France
Hôpital privé du Confluent

Nantes, 44277, France
Integral Healthcare

Adelaide, 5068, Australia
Lyell McEwin Hospital

Elizabeth Vale, 5112, Australia
Noordwest Ziekenhuisgroep

Alkmaar, 1815 JD, Netherlands
UZ Gent - Universitair Ziekenhuis Gent

Ghent, 9000, Belgium
Victorian Heart Hospital

Clayton, 3168, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.